CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

March 28th, 2014

ACC.14 Headquarters

wpengine

CardioExchange is dedicated to bringing you the latest from ACC.14. Check out our coverage of the conference ─ and some of the great debates these posts have sparked ─ then tell us what you think!

News:

No Benefit Found in First Real Test of Renal Denervation

Survival Advantage for TAVR Over Surgery in High-Risk Patients

First TAVR Comparison Trial Favors Sapien XT Over CoreValve

MADIT-CRT Long-Term Follow-Up Shows Survival Benefit with CRT-D

High-Sensitivity Troponin Test Could Identify Low-Risk Chest Pain Patients in the ED

Aspirin and Clonidine Fail to Help Surgery Patients

Novartis Trial Was Stopped Early Because of a Significant Drop in Cardiovascular Mortality

Analysis:

Negative Findings on Renal Denervation for Hypertension: Sweet SYMPLICITY?

TAVR: Are You Impressed Now?

Long-Term Follow-Up from MADIT-CRT: Guideline Implications

Are We Equipped to Make a CHOICE Between TAVR Devices?

Follow our Fellows:

Changing My Priorities for ACC.14

Ideals Lost, But Not Stolen

Are Digital Conferences the Way of the Future?

Taking Patient-Centerdness to the Next Level at ACC.14

Stage Set for Phase IV Trials of PCSK9 Inhibition

Master of all Trades

Categories: General

You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.

NEJM Journal Watch is a publication of NEJM Group,
a division of the Massachusetts Medical Society.

NEJM Group

Copyright © 2021 Massachusetts Medical Society.
All rights reserved.